Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

RABBANI SHAHRAM K

2. Issuer Name and Ticker or Trading Symbol
ENZO BIOCHEM INC [ENZ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Treasurer, Secretary

(Last)

(First)

(Middle)

C/O ENZO BIOCHEM, INC., 527 MADISON AVENUE

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2009

(Street)

NEW YORK, NY 10022

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01	07/01/2009		J⁽¹⁾⁽²⁾		82,645	A	⁽¹⁾ ⁽²⁾	1,539,392 ⁽³⁾	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
RABBANI SHAHRAM K C/O ENZO BIOCHEM, INC. 527 MADISON AVENUE NEW YORK, NY 10022	X		Treasurer, Secretary

Signatures

/s/ Shahram K. Rabbani		07/06/2009
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	On July 18, 2008, the Reporting Person exchanged 82,645 shares of common stock of the Issuer (the "Shares") in connection with the acquisition of certain real estate from a third-party. At such time, pursuant to a loan agreement dated July 18, 2008 (the "Loan Agreement") by and between the Reporting Person and such third-party (the "Borrower"), the Reporting Person loaned the Borrower $500,000, which was evidenced by a promissory note dated July 18, 2008 (the "Promissory Note") and secured by a pledge of the Shares pursuant to a stock pledge agreement dated July 18, 2008 (the "Pledge Agreement") by and between the Reporting Person, as pledge agent, the Borrower, and certain other parties named therein (the "Transaction"). Under the terms of the Transaction, the Shares were held in escrow by the Reporting Person, as pledge agent, and, upon a default under the terms of (CONTINUED IN FOOTNOTE 2)
(2)	the Loan Agreement, the Reporting Person would be entitled, as pledge agent, to foreclose on the Shares under the Pledge Agreement. The Pledge Agreement provides that upon such foreclosure, the Reporting Person, as pledge agent, has the right to have the Shares transferred to him and registered in his name or in the name of his nominee. The Transaction was reported by the Reporting Person on a Form 4 filed with the Securities and Exchange Commission on July 22, 2008. On January 20, 2009, a notice of default was sent to the Borrower and the Reporting Person subsequently foreclosed on the Shares. On July 1, 2009, the Reporting Person exercised his right, as pledge agent, under the Pledge Agreement to have the Shares transferred to him and registered in his name, and the Shares were so transferred on such date. Accordingly, this Form 4 is being filed to report such transfer from the Borrower to the Reporting Person.
(3)	Includes: (i) 1,671 shares of Common Stock that the Reporting Person holds as custodian for certain of his nephews; (ii) 1,354 shares of Common Stock held in the name of the Reporting Person's son and (iii) 7,995 shares of Common Stock held in the Company's 401(k) plan.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.